145 related articles for article (PubMed ID: 15185141)
1. Interaction effect of PTEN and CDKN1B chromosomal regions on prostate cancer linkage.
Xu J; Langefeld CD; Zheng SL; Gillanders EM; Chang BL; Isaacs SD; Williams AH; Wiley KE; Dimitrov L; Meyers DA; Walsh PC; Trent JM; Isaacs WB
Hum Genet; 2004 Aug; 115(3):255-62. PubMed ID: 15185141
[TBL] [Abstract][Full Text] [Related]
2. Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse.
Di Cristofano A; De Acetis M; Koff A; Cordon-Cardo C; Pandolfi PP
Nat Genet; 2001 Feb; 27(2):222-4. PubMed ID: 11175795
[TBL] [Abstract][Full Text] [Related]
3. Absence of PTEN germ-line mutations in men with a potential inherited predisposition to prostate cancer.
Cooney KA; Tsou HC; Petty EM; Miesfeldt S; Ping XL; Gruener AC; Peacocke M
Clin Cancer Res; 1999 Jun; 5(6):1387-91. PubMed ID: 10389923
[TBL] [Abstract][Full Text] [Related]
4. A polymorphism in the CDKN1B gene is associated with increased risk of hereditary prostate cancer.
Chang BL; Zheng SL; Isaacs SD; Wiley KE; Turner A; Li G; Walsh PC; Meyers DA; Isaacs WB; Xu J
Cancer Res; 2004 Mar; 64(6):1997-9. PubMed ID: 15026335
[TBL] [Abstract][Full Text] [Related]
5. Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression.
Kwabi-Addo B; Giri D; Schmidt K; Podsypanina K; Parsons R; Greenberg N; Ittmann M
Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11563-8. PubMed ID: 11553783
[TBL] [Abstract][Full Text] [Related]
6. Infrequent genetic alterations of the PTEN gene in Japanese patients with sporadic prostate cancer.
Orikasa K; Fukushige S; Hoshi S; Orikasa S; Kondo K; Miyoshi Y; Kubota Y; Horii A
J Hum Genet; 1998; 43(4):228-30. PubMed ID: 9852672
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer: simplicity to complexity.
Peters ME; Ostrander EA
Nat Genet; 2001 Feb; 27(2):134-5. PubMed ID: 11175773
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity and microsatellite instability at chromosomal sites 1Q and 10Q in morphologically distinct regions of late stage prostate lesions.
Latini JM; Rieger-Christ KM; Wang DS; Silverman ML; Libertino JA; Summerhayes IC
J Urol; 2001 Nov; 166(5):1931-6. PubMed ID: 11586263
[TBL] [Abstract][Full Text] [Related]
9. Analysis of PTEN and the 10q23 region in primary prostate carcinomas.
Feilotter HE; Nagai MA; Boag AH; Eng C; Mulligan LM
Oncogene; 1998 Apr; 16(13):1743-8. PubMed ID: 9582022
[TBL] [Abstract][Full Text] [Related]
10. PTEN polymorphism (IVS4) is not associated with risk of prostate cancer.
George DJ; Shepard TF; Ma J; Giovannucci E; Kantoff PW; Stampfer MJ
Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):411-2. PubMed ID: 11319185
[No Abstract] [Full Text] [Related]
11. PTEN up-regulates the tumor metastasis suppressor gene Drg-1 in prostate and breast cancer.
Bandyopadhyay S; Pai SK; Hirota S; Hosobe S; Tsukada T; Miura K; Takano Y; Saito K; Commes T; Piquemal D; Watabe M; Gross S; Wang Y; Huggenvik J; Watabe K
Cancer Res; 2004 Nov; 64(21):7655-60. PubMed ID: 15520163
[TBL] [Abstract][Full Text] [Related]
12. Mutations of PTEN/MMAC1 in primary prostate cancers from Chinese patients.
Dong JT; Li CL; Sipe TW; Frierson HF
Clin Cancer Res; 2001 Feb; 7(2):304-8. PubMed ID: 11234884
[TBL] [Abstract][Full Text] [Related]
13. CDKN1A and CDKN1B polymorphisms and risk of advanced prostate carcinoma.
Kibel AS; Suarez BK; Belani J; Oh J; Webster R; Brophy-Ebbers M; Guo C; Catalona WJ; Picus J; Goodfellow PJ
Cancer Res; 2003 May; 63(9):2033-6. PubMed ID: 12727815
[TBL] [Abstract][Full Text] [Related]
14. Linkage analysis of 153 prostate cancer families over a 30-cM region containing the putative susceptibility locus HPCX.
Lange EM; Chen H; Brierley K; Perrone EE; Bock CH; Gillanders E; Ray ME; Cooney KA
Clin Cancer Res; 1999 Dec; 5(12):4013-20. PubMed ID: 10632333
[TBL] [Abstract][Full Text] [Related]
15. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues.
Suzuki H; Freije D; Nusskern DR; Okami K; Cairns P; Sidransky D; Isaacs WB; Bova GS
Cancer Res; 1998 Jan; 58(2):204-9. PubMed ID: 9443392
[TBL] [Abstract][Full Text] [Related]
16. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.
Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C
Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387
[TBL] [Abstract][Full Text] [Related]
17. Homozygous deletion of the PTEN tumor suppressor gene in a subset of prostate adenocarcinomas.
Wang SI; Parsons R; Ittmann M
Clin Cancer Res; 1998 Mar; 4(3):811-5. PubMed ID: 9533551
[TBL] [Abstract][Full Text] [Related]
18. No evidence of germline PTEN mutations in familial prostate cancer.
Forrest MS; Edwards SM; Hamoudi RA; Dearnaley DP; Arden-Jones A; Dowe A; Murkin A; Kelly J; Teare MD; Easton DF; Knowles MA; Bishop DT; Eeles RA
J Med Genet; 2000 Mar; 37(3):210-2. PubMed ID: 10777362
[No Abstract] [Full Text] [Related]
19. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome.
Liaw D; Marsh DJ; Li J; Dahia PL; Wang SI; Zheng Z; Bose S; Call KM; Tsou HC; Peacocke M; Eng C; Parsons R
Nat Genet; 1997 May; 16(1):64-7. PubMed ID: 9140396
[TBL] [Abstract][Full Text] [Related]
20. MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer.
Koul D; Shen R; Garyali A; Ke LD; Liu TJ; Yung WK
Int J Oncol; 2002 Sep; 21(3):469-75. PubMed ID: 12168088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
